Establishment Labs Corp (ESTA) - Debt to Equity

ESTA (Establishment Labs) - company brandmark

Establishment Labs (ESTA) minimizes risks in the aesthetics sector by supplying advanced silicone implants to over 80 countries. Innovative breast prostheses with enhanced safety are currently rapidly capturing the US market. The debt-to-equity ratio dynamics, where 12.32 reflects the current volume of the metric, complement management's strategy of technological displacement of competitors and transparent international expansion.

establishmentlabs.com - ESTA Debt to Capital (period 07/04/2022 - 10/28/2026)
Flagship merchandise of Establishment Labs Inc

The selection of reliable issuers is based on a rigorous analysis of debt load and balance sheet stability. This ratio determines the proportion of borrowed funds to equity, measuring the business's degree of dependence on creditors. For Establishment Labs (ESTA), with its premium image in aesthetic surgery, low leverage confirms financial autonomy during expansion. By analyzing the company's leverage history, an investor can assess default risks or growth potential.

Main competitors

BSX: Debt to Equity|Total Debt to Capital Coefficient EW|RMD - Debt to Equity|Aggregate Debt to Equity Insulet Inc. (PODD)|ZBH: Total Debt to Capital|Debt to Capital coopercos.com COO|ALGN: Total Debt to Capital|GMED - Total Debt to Equity Ratio|TransMedics - Total Debt to Capital|Alphatec Corp (ATEC) - Total Debt to Capital Coefficient|AORT (Artivion, Inc.) - Total Debt to Capital|Total Debt to Capital ENOV|Debt to Equity Integra LifeSciences Holdings Corporation (IART)|Debt to Equity Beta Bionics, Inc. (BBNX)|Total Debt to Capital IRMD|EMBC - Total Debt to Capital Coefficient|Total Debt to Equity Ratio Tandem Diabetes Care|AXGN - Aggregate Debt to Equity|Total Debt to Capital SIBN|Orthofix Medical (OFIX) - Debt to Capital|Total Debt to Capital Bioventus Corp (BVS)|Debt to Equity Ratio OrthoPediatrics Inc. (KIDS)|Treace Medical Concepts (TMCI) - Total Debt to Equity Ratio|All Debt to Shareholders' Equity Ratio SRTA (blade.com)|Carlsmed - Debt to Equity|Total Debt to Equity Ratio RxSight Inc RXST|CLPT (ClearPoint) - Total Debt to Capital|STXS - Debt to Capital|Total Debt to Capital Neuronetics, Inc.|sightsciences.com (SGHT) - Debt to Equity Ratio|OBIO: Total Debt to Capital|Total Debt to Capital Coefficient Anika|Total Debt to Capital NSPR (InspireMD Corp)|Total Debt to Equity Ratio zhjmedical.com (ZJYL)|Total Debt to Capital VANI (Vivani Medical)|Xtant Medical Holdings, Inc. - Total Debt to Capital|NMTC - Debt to Equity|Modular Medical (MODD) - Debt to Equity|Total Debt to Equity Ratio Myomo, Inc MYO|Envoy Medical Inc (COCH) - All Debt to Shareholders' Equity Ratio|Total Debt to Capital VVOS (Vivos Therapeutics)|Debt to Capital NVNO|SINT: Debt to Equity|Debt to Capital Ratio Tenon Medical Inc. TNON|Total Debt to Equity Ratio LFWD (ReWalk Robotics Ltd)|Total Debt to Capital Autonomix Medical Inc. AMIX|Total Debt to Capital IVF (INVO Fertility Inc)|BBLG: Total Debt to Capital Coefficient|Debt to Equity Axonics (AXNX)|BIOL (BIOLASE Inc.) - Aggregate Debt to Equity|Debt to Equity DYNT|Total Debt to Equity Ratio Paragon 28 Corp|INVO Bioscience, Inc. - Total Debt to Capital